Background: Epicardial adipose tissue (EAT) has garnered attention as a prognostic and
risk stratification factor for cardiovascular disease. This study, via meta-analyses, evaluates …

Background Previous studies have shown that females with type 2 diabetes mellitus (T2DM)
may have excess mortality risk compared to their male counterparts. An important next step …

Background Understanding the trajectories of metabolic risk factors for acute myocardial
infarction (AMI) is necessary for healthcare policymaking. We estimated future projections of …

The silent obesity epidemic has led to the rising global prevalence of non-alcoholic fatty liver
disease (NAFLD). This metabolic burden is a growing public health concern as forecast …

The metabolic syndrome, characterized by type 2 diabetes mellitus (T2DM), hypertension,
hyperlipidemia, and obesity, collectively increases the risk of cardiovascular diseases …

Context Polyphenols are plant-based compounds with potential anti-inflammatory,
antioxidant, and anti-obesogenic properties. However, their effects on health outcomes …

Aim Patients with metabolic dysfunction‐associated steatotic liver disease (MASLD) are at
increased risk of incident cardiovascular disease. However, the clinical characteristics and …

Background Given the rapidly growing burden of cardiovascular disease (CVD) in Asia, this
study forecasts the CVD burden and associated risk factors in Asia from 2025 to 2050 …

Background Inflammation is a key driver of atherosclerotic diseases and is often
accompanied by disease-related malnutrition. However, the long-term burden of …

Background Obesity paradox has been reported in patients with cardiovascular disease,
showing an inverse association between obesity as defined by BMI (in kg/m 2) and …